- Abbott seeks to terminate $5.8-bn acquisition of Alere 08 December 2016
- Alere sues Abbott for completion of $5.8-bn merger 29 August 2016
- P&G follows Pfizer, Abbot, ends sale of cold remedy 15 March 2016
- India bans Pfizer, Abbot cough syrups; shares tank 14 March 2016
- Abbott to buy rapid diagnostic testing provider Alere for $5.8 bn 02 February 2016
- Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa 21 September 2015
- New intraocular lens helps cataract-affected see better 07 August 2015
- Abbott Laboratories to back Mylan-Perrigo deal 17 June 2015
- Russia blocks Abbott Laboratories - Petrovax merger 20 April 2013
- Abbott to pay $1.3 bn to settle Depakote epilepsy drug claims 24 October 2011
- Abott to split into two 19 October 2011
- India rejects HIV drug patent application by Abbott Laboratories 03 January 2011
- Solvay Pharma to merge with Abbott India in a 3:2 share swap 25 November 2010
- Abbott to keep Piramal business separate after acquisition 11 September 2010
- Abbott completes acquisition of Starlims Technologies 23 March 2010
- Abbott bids for 20 per cent of Solvay India 17 February 2010
- Bombay HC rejects plea to block Wockhardt deal with Abbott 18 January 2010
- Abbott to acquire Starlims Technologies for $123 million 15 December 2009
- Abbott to acquire Belgian drug company Solvay for $6.6 billion 29 September 2009
- Abbott expands vision care portfolio; buys Visiogen 03 September 2009
- Abbott India to buy back shares at Rs 650 26 August 2006
- Abbott onthe block 24 December 2001
- Abbott Labs diversifying 01 September 1998
- Abbott's new businesses, low-cost oppurtunism 01 September 1998